Nonalcoholic Steatohepatitis
📧 Sign up to get email alerts when something new happens for Nonalcoholic Steatohepatitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-03-19Clinical Trial Update: Tesamorelin for Reduction of Liver Fat in Adults With Fatty Liver Disease (Mock Study) [Phase 2]
Phase 2 clinical trial evaluating tesamorelin to reduce liver fat in adults with metabolic steatotic liver disease and related conditions. T…
-
CLINICAL_TRIALS research · 2026-03-18Clinical Trial Update: A Randomized, Double-Blind, Placebo Controlled Study to Assess the Efficacy and Safety of SNP-610 for the Treatment of Patients With Non-alcoholic Steatohepatitis [Phase 2]
A Phase 2 randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of SNP-610 for treating nonalcoholic steato…
-
CLINICAL_TRIALS research · 2026-03-17Clinical Trial Update: Expanded Studies on the SCAPIS Stockholm Reexamination Cohort
This clinical trial update indicates expanded studies for the SCAPIS Stockholm Reexamination Cohort sponsored by Danderyd Hospital, covering…
-
CLINICAL_TRIALS research · 2026-03-13Clinical Trial Update: Study to Evaluate Safety, Tolerability and Pharmacokinetics of CS060304 in Healthy and Elevated LDL-C Subjects [Phase 1]
A Phase 1 study to evaluate safety, tolerability, and pharmacokinetics of CS060304 in healthy subjects and individuals with elevated LDL-C; …
-
CLINICAL_TRIALS research · 2026-03-12Clinical Trial Update: A Phase 2 Clinical Trial to Evaluate the Efficacy and Safety of VSA006 in Chinese NASH Patients [Phase 2]
Phase 2 trial evaluating the efficacy and safety of VSA006 in Chinese patients with nonalcoholic steatohepatitis is currently active but not…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-03-12Clinical Trial Update: Exercise for an Aging Liver (EXALIVER) [NA]
EXALIVER is a clinical trial evaluating exercise as an intervention for MASLD and MASH-related liver disease, with the study currently not y…
-
CLINICAL_TRIALS trial_result · 2026-03-10Clinical Trial Update: Quantifying Body Composition and Liver Disease in Children Using Free-Breathing MRI and MRE
A pediatric imaging trial using free-breathing MRI and MR elastography to quantify body composition and liver disease has completed.
-
CLINICAL_TRIALS trial_result · 2026-03-02Clinical Trial Update: A Clinical Study of Efinopegdutide in People With Compensated Cirrhosis Due to Steatohepatitis (MK-6024-017) [Phase 2]
Phase 2 study MK-6024-017 evaluating efinopegdutide in compensated cirrhosis due to nonalcoholic fatty liver disease and nonalcoholic steato…
-
CLINICAL_TRIALS trial_result · 2026-02-20Clinical Trial Update: Study Evaluating the Efficacy and Safety of Belapectin for the Prevention of Esophageal Varices in NASH Cirrhosis [Phase 2, Phase 3]
The Phase 2/Phase 3 trial evaluating belapectin for the prevention of esophageal varices in NASH-related cirrhosis has been terminated.
-
CLINICAL_TRIALS research · 2026-02-19Clinical Trial Update: Thyroid Hormone for Treatment of Nonalcoholic Steatohepatitis in Veterans [Phase 2]
A Phase 2 clinical trial is investigating thyroid hormone as a treatment for nonalcoholic steatohepatitis with liver fibrosis in veterans, a…
-
CLINICAL_TRIALS research · 2026-02-11Clinical Trial Update: Evaluation of Miricorilant on Liver Fat in Patients With MASLD [Phase 1]
Phase 1 clinical trial evaluating Miricorilant on liver fat in patients with MASLD, including NASH and related conditions; currently recruit…
-
CLINICAL_TRIALS research · 2026-02-10Clinical Trial Update: Stimulating Fat Tissue Storage With Niacin to Reduce Fat Accumulation in the Liver. [NA]
A clinical trial update from Université de Sherbrooke indicates recruitment for a study testing niacin to stimulate fat storage in adipose t…
-
CLINICAL_TRIALS research · 2026-02-09Clinical Trial Update: Tocotrienol Against the Progression of End Stage Liver Disease [Phase 2]
Phase 2 clinical trial evaluating tocotrienol to slow progression of end-stage liver disease, including nonalcoholic steatohepatitis and non…
-
CLINICAL_TRIALS research · 2026-01-28Clinical Trial Update: Investigating the Link Between Type 2 Immunity and NAFLD in Human Obesity
A Mayo Clinic-led clinical trial is recruiting to investigate how Type 2 immunity relates to nonalcoholic fatty liver disease (NAFLD) in peo…
-
CLINICAL_TRIALS trial_result · 2026-01-21Clinical Trial Update: Role of Lisinopril in Preventing the Progression of Non-Alcoholic Fatty Liver Disease, RELIEF-NAFLD Study [Phase 2]
Phase 2 RELIEF-NAFLD trial update evaluating lisinopril to prevent progression of non-alcoholic fatty liver disease and nonalcoholic steatoh…
-
CLINICAL_TRIALS research · 2026-01-20Clinical Trial Update: Statins for the Treatment of NASH [Phase 2]
A Phase 2 clinical trial evaluating statins for nonalcoholic steatohepatitis (NASH) is currently active but not recruiting.
-
CLINICAL_TRIALS research · 2026-01-15Clinical Trial Update: Nonalcoholic Fatty Liver Disease in HIV Database
This entry describes a clinical trial registry study on nonalcoholic fatty liver disease and nonalcoholic steatohepatitis in people living w…
-
CLINICAL_TRIALS research · 2026-01-15Clinical Trial Update: ENDOCARE-SCREEN: Metabolic Liver Dysfunction Screening Study
ENDOCare-SCREEN is a screening study for metabolic liver dysfunction and related metabolic conditions, currently not recruiting.
-
CLINICAL_TRIALS trial_result · 2026-01-12Clinical Trial Update: A Clinical Study of Efinopegdutide in Participants With Precirrhotic Nonalcoholic Steatohepatitis (NASH) (MK-6024-013) [Phase 2]
Phase 2 study of efinopegdutide in participants with precirrhotic nonalcoholic steatohepatitis (NAFLD/NASH) has completed.
-
CLINICAL_TRIALS research · 2026-01-08Clinical Trial Update: Hepatic Energy Fluxes in NASH and NAS Patients [NA]
This entry reports an ongoing University of Minnesota clinical trial studying hepatic energy flux in patients with nonalcoholic steatohepati…
-
CLINICAL_TRIALS trial_result · 2026-01-07Clinical Trial Update: Genomic Resources for Enhancing Available Therapies (GREAT1.0) Study
The GREAT1.0 genomic resources study is currently suspended, with no trial results reported at this time.
-
CLINICAL_TRIALS trial_result · 2026-01-06Clinical Trial Update: Study Evaluating the Safety, Efficacy and Tolerability of BIO89-100 in Subjects With Biopsy-confirmed Nonalcoholic Steatohepatitis (NASH) [Phase 2]
A Phase 2 study evaluating BIO89-100 in adults with biopsy-confirmed nonalcoholic steatohepatitis has completed, and the results have been p…
-
CLINICAL_TRIALS trial_result · 2026-01-06Clinical Trial Update: The Impact of Ibutamoren on Nonalcoholic Fatty Liver Disease [Phase 2]
Phase 2 trial studying ibutamoren for nonalcoholic fatty liver disease has completed and posted results. The study was sponsored by Massachu…
-
CLINICAL_TRIALS research · 2025-12-29Clinical Trial Update: A Trial to Evaluate the Efficacy, Safety, PK, and PD of HP515 in Non - Alcoholic Fatty Liver Disease ( NASH/MASH ) [Phase 2]
A Phase 2 clinical trial evaluating HP515 for non-alcoholic fatty liver disease, including potential nonalcoholic steatohepatitis, is curren…
-
CLINICAL_TRIALS trial_result · 2025-12-26Clinical Trial Update: IMPACT TRIAL: Efficacy and Safety of Pemvidutide in Subjects With Nonalcoholic Steatohepatitis (NASH) [Phase 2]
A Phase 2 trial evaluating the efficacy and safety of pemvidutide in nonalcoholic steatohepatitis has completed, with results on its perform…